- Home
- DCTH vs CHCT Comparison
DCTH vs CHCT Comparison
Compare DCTH & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- CHCT
- Stock Information
- Founded
- DCTH 1988
- CHCT 2014
- Country
- DCTH United States
- CHCT United States
- Employees
- DCTH N/A
- CHCT N/A
- Industry
- DCTH Medical/Dental Instruments
- CHCT Real Estate Investment Trusts
- Sector
- DCTH Health Care
- CHCT Real Estate
- Exchange
- DCTH Nasdaq
- CHCT Nasdaq
- Market Cap
- DCTH 630.4M
- CHCT 422.2M
- IPO Year
- DCTH N/A
- CHCT 2015
- Fundamental
- Price
- DCTH $16.21
- CHCT $16.34
- Analyst Decision
- DCTH Strong Buy
- CHCT Buy
- Analyst Count
- DCTH 4
- CHCT 4
- Target Price
- DCTH $24.00
- CHCT $21.00
- AVG Volume (30 Days)
- DCTH 610.5K
- CHCT 196.0K
- Earning Date
- DCTH 05-08-2025
- CHCT 07-29-2025
- Dividend Yield
- DCTH N/A
- CHCT 11.41%
- EPS Growth
- DCTH N/A
- CHCT N/A
- EPS
- DCTH N/A
- CHCT N/A
- Revenue
- DCTH $53,850,000.00
- CHCT $116,531,000.00
- Revenue This Year
- DCTH $141.47
- CHCT $7.14
- Revenue Next Year
- DCTH $49.31
- CHCT $7.04
- P/E Ratio
- DCTH N/A
- CHCT N/A
- Revenue Growth
- DCTH 1068.87
- CHCT 1.33
- 52 Week Low
- DCTH $6.33
- CHCT $14.76
- 52 Week High
- DCTH $18.23
- CHCT $27.62
- Technical
- Relative Strength Index (RSI)
- DCTH 58.15
- CHCT 48.18
- Support Level
- DCTH $16.02
- CHCT $15.62
- Resistance Level
- DCTH $17.29
- CHCT $16.85
- Average True Range (ATR)
- DCTH 0.99
- CHCT 0.39
- MACD
- DCTH -0.03
- CHCT 0.02
- Stochastic Oscillator
- DCTH 49.63
- CHCT 54.96
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.